Natco Pharma Q2 Results: Earnings lower than last year on all fronts

Natco Pharma declared an interim dividend of ₹1.50 per equity share of face value ₹2 for the financial year 2025-26.

Leave a Reply

Your email address will not be published. Required fields are marked *